Perspective Therapeutics (CATX) Interest Coverage Ratio (2010 - 2026)
Perspective Therapeutics' (CATX) quarterly Interest Coverage Ratio came in at 269.34 in Q1 2026, down 57.91% year-on-year from 639.99 in Q1 2025, and up 56.72% quarter-over-quarter from 622.38 in Q4 2025.
Perspective Therapeutics (CATX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Perspective Therapeutics has disclosed Interest Coverage Ratio across 11 years of filings, most recently posting 269.34 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 269.34, down 57.91% year-over-year; the trailing twelve-month figure through Mar 2026 was 339.98 (up 49.88% YoY), and the FY2025 annual result was 302.03, up 84.05% from the prior year.
- Interest Coverage Ratio came in at 269.34 for Q1 2026 at Perspective Therapeutics, up from 622.38 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 616.22 in Q4 2024 to a low of 696.43 in Q3 2023.
- The 4-year median for Interest Coverage Ratio is 428.63 (2025), against an average of 347.36.
- Across the five-year window, Interest Coverage Ratio surged 226.66% in 2024 and tumbled 201.0% in 2025, its largest moves.
- Perspective Therapeutics' Interest Coverage Ratio stood at 486.5 in 2023, then soared by 226.66% to 616.22 in 2024, then sank by 201.0% to 622.38 in 2025, then jumped by 56.72% to 269.34 in 2026.
- The last three Interest Coverage Ratio figures came in at 269.34 (Q1 2026), 622.38 (Q4 2025), and 428.63 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | -269.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -269.34 |
| Dec 31, 2025 | -622.38 |
| Sep 30, 2025 | -428.63 |
| Jun 30, 2025 | -202.01 |
| Mar 31, 2025 | -170.56 |
| Dec 31, 2024 | 616.22 |
| Sep 30, 2024 | -270.06 |
| Jun 30, 2024 | -620.13 |
| Mar 31, 2024 | -448.45 |
| Dec 31, 2023 | -486.50 |
| Sep 30, 2023 | -696.43 |
| Jun 30, 2023 | -375.15 |
| Mar 31, 2023 | -542.28 |
| Jun 30, 2016 | -25,080.00 |
| Sep 30, 2015 | -1,148.42 |
| Jun 30, 2015 | 712.17 |
| Mar 31, 2015 | -10,510.12 |
| Sep 30, 2014 | -336.45 |
| Jun 30, 2014 | -23,577.45 |
| Dec 31, 2013 | -12,143.80 |